Meeting report - EMA workshop on the challenges in drug development, regulation and clinical practice for immunoglobulins
Cancer Medicines Forum: September 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 September 2025, 14:00 (CEST) to 4 September 2025, 17:00 (CEST)
Minutes of the Cancer Medicines Forum - September 2025
Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation: 11/02/2021, Revision: 11, Status: Authorised
Product Management Service (PMS) – Frequently Asked Questions (FAQs)
Human medicines European public assessment report (EPAR): Accofil, filgrastim, Date of authorisation: 17/09/2014, Revision: 19, Status: Authorised
Scientific recommendations on classification of advanced therapy medicinal products
Minutes of the COMP meeting 7-8 October 2025
Step-by-step guide: How to evaluate a CT application - CTIS Training Programme - Module 06
European Medicines Agency’s data protection notice for PMS user acceptance stakeholder involvement